Clinical trial · Interventional
Feasibility of Aromatherapy in an Awake Craniotomy Environment
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Awake craniotomy for tumor surgery allows for mapping of speech, motor and sensory function during tumor resection. Awake craniotomy is increasingly utilized as it has several advantages over a traditional general anesthetic technique. Though many patients tolerate awake cranial surgery well, recent studies found that roughly 30% of patients experience moderate to severe pain and anxiety, while 50% report moderate fear and 11% report severe fear. Therefore, alternative methods to mitigate pain, anxiety, and fear are needed. In this study, the investigators will employ lavender aromatherapy to reduce anxiety and improve the satisfaction with pain control.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Intracranial Pathology | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Lavender (Lavandula angustifolia) | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Treatment with Lavender
- description
- Lavender (Lavandula angustifolia) aromatherapy will be administered at regular intervals using a nasal inhaler.
- interventionNames
- Drug: Lavender (Lavandula angustifolia)
Primary outcomes (2)
- measure
- Number of Consented Patients
- timeFrame
- From recruitment to end of enrollment period
- description
- Determine the number of eligible patients enrolled and consented
- measure
- Protocol Completion
- timeFrame
- From the preoperative evaluation through the post operative evaluation in the Neurosurgical Intensive Care Unit (NICU)
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Any adult patient aged 18 and older undergoing awake cranial neurosurgery Exclusion Criteria: * Allergy or sensitivity to the aromatherapy agent (Lavender) * Aversion to lavender scent * History of asthma, chronic obstructive pulmonary disease (COPD) * History of contact dermatitis following exposure to cosmetic fragrances * Pregnancy
References
Publications (0)
Data not yet available